FDA Approvals News
Latest fda approvals news, reviewed by pharmacists.
FDA Approvals articles
FDA ApprovalsNew Cancer Rx Gets Green Light
Keytruda (pembrolizumab) approved to treat cancers with specific biomarker
FDA ApprovalsADHD Rx Goes Generic
Strattera generic atomoxetine approved to treat ADHD
FDA ApprovalsBlood Vessel Inflammation Rx Approved
Actemra (tocilizumab) receives FDA approval to treat giant cell arteritis
FDA ApprovalsFirst-of-Its-Kind Device Treats Birth Defect
Flourish Pediatric Esophageal Atresia Anastomosis approved to treat gap in the esophagus
FDA ApprovalsA New Rx for ALS
Radicava (edaravone) approved to treat amyotrophic lateral sclerosis (ALS)
FDA ApprovalsNew Cancer Rx Gets FDA Thumbs Up
Imfinzi (durvalumab) approved to treat cancer of the bladder and urinary tract
FDA ApprovalsThere's a New Treatment for Batten Disease
Brineura (cerliponase alfa) approved to treat symptoms of a form of Batten disease
FDA ApprovalsNew Rx Treats Common Blood Cancer
Rydapt (midostaurin) approved to treat acute myeloid leukemia
FDA ApprovalsFirst Liver Cancer Rx in Almost 10 Years
Stivarga (regorafenib) approved by FDA to treat liver cancer
FDA ApprovalsLung Cancer Gets New Treatment
Alunbrigtm (brigatinib) approved to treat non-small cell lung cancer
FDA ApprovalsAnother Biosimilar Gets a Green Light
Renflexis (infliximab-abda), a biosimilar to Remicade (infliximab), approved
FDA ApprovalsA Shocking Treatment for Cluster Headaches
FDA approves gammaCore, a nonsurgical treatment for cluster headaches
FDA ApprovalsFirst Tardive Dyskinesia Rx Approved
Ingrezza (valbenazine) approved to treat tardive dyskinesia
FDA ApprovalsThere's a New Rx for a Common Huntington's Symptom
Austedo (deutetrabenazine) approved to treat chorea tied to Huntington's disease
FDA ApprovalsNew Options for Children with Hep C
Sovaldi and Harvoni approved to treat hepatitis C in children
FDA ApprovalsNew Multiple Sclerosis Rx Gets Approval
Ocrevus (ocrelizumab) is first FDA-approved primary progressive multiple sclerosis treatment
FDA ApprovalsThere's a New Rx for Eczema
Dupixent (dupilumab) approved to treat moderate to severe eczema
FDA ApprovalsNew Cancer Rx Gets FDA Nod
Zejula (niraparib) approved to treat various forms of cancer
FDA ApprovalsOpioid-Induced Constipation Rx Approved
Symproic (naldemedine) approved to treat opioid-induced constipation
FDA ApprovalsFDA Approves First Rx for Rare Cancer
Bavencio (avelumab) approved as first Merkel cell carcinoma treatment
FDA ApprovalsNew Parkinson's Rx Gets FDA Nod
Xadago (safinamide) approved as Parkinson's disease add-on therapy
FDA ApprovalsKeytruda Gets a New Job
Pembrolizumab (brand name Keytruda) approved for classical Hodgkin lymphoma
FDA ApprovalsFDA OKs Rx for 'Smile Lines'
Juvederm Vollure XC approved by FDA to combat nasolabial folds
FDA ApprovalsNew Breast Cancer Rx Approved
Kisqali (ribociclib) approved to treat HR-positive, HER2-negative breast cancer